A Safety and Effectiveness Study of a New Multi-Purpose Contact Lens Care Solution

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

315 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-04-23

Study Completion Date

2018-10-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective of this study is to evaluate the safety and effectiveness of ASP-57 Multi-Purpose contact lens solution (Test) compared to ReNu® Multiplus Contact Lens Solution (Control) when used by habitual contact lens wearers to bilaterally clean and disinfect their contact lenses for approximately 3 months (12 weeks).

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Evaluation of an Investigational Multi-Purpose Disinfecting Solution for Care of Soft Contact Lenses

NCT00382681

Contact Lens Care

COMPLETED NA

A Study to Evaluate the Safety and Effectiveness of a Contact Lens Cleaning and Disinfecting Solution

NCT05565937

Refractive Ametropia

COMPLETED NA

An Evaluation of Marketed Contact Lens Disinfectant Systems on Eyelid Tissues

NCT01594294

Myopia

COMPLETED NA

Evaluation of Marketed Contact Lens Disinfectant Systems on Eyelid Tissues

NCT01494818

Contact Lens Care

COMPLETED NA

Evaluation of an Investigational Multi-Purpose Disinfecting Solution for the Care of Soft Contact Lenses in Symptomatic Patients

NCT00382603

Contact Lens Care

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Approximately 330 subjects (660 eyes) will be enrolled in this 3 month (12 week) controlled, parallel group, masked, randomized study at approximately 15 investigative sites in the United States. Subjects will be randomized 2:1 to receive either Asepticys ASP-57 Multi-Purpose Solution or ReNu® Multiplus Contact Lens Solution (Control) respectively. Both Test and Control solution will be used with a rub care regimen.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Contact Lens Wear

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Asepticys investigational ASP-57 Multi-Purpose Solution

ASP-57 Multi-Purpose contact lens care solution used as a rub care regimen (Test)

Group Type EXPERIMENTAL

ASP-57

Intervention Type DEVICE

an experimental solution for disinfecting, cleaning, conditioning, rinsing, protein removal, ad storing soft contact lenses including silicone hydrogel lenses

ReNu® Multiplus Contact Lens Solution

ReNu® Multiplus Contact Lens Solution used as rub care regimen (Control)

Group Type ACTIVE_COMPARATOR

ReNu® Multiplus

Intervention Type DEVICE

a multi-purpose solution for disinfecting, cleaning, conditioning, rinsing, protein removal, ad storing soft contact lenses including silicone hydrogel lenses

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

ASP-57

an experimental solution for disinfecting, cleaning, conditioning, rinsing, protein removal, ad storing soft contact lenses including silicone hydrogel lenses

Intervention Type DEVICE

ReNu® Multiplus

a multi-purpose solution for disinfecting, cleaning, conditioning, rinsing, protein removal, ad storing soft contact lenses including silicone hydrogel lenses

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Investigational Multi-Purpose Contact Lens Care Solution

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Subjects age ≥ 18 years on the date of informed consent.
2. All subjects must provide signed written consent prior to participation in any study related procedures.
3. Successful history of wear of the one of the following lens types (toric and multifocal lenses of the specified lens type are allowed) in both eyes during the past 3 months, and history of at least 5 consecutive days of successful daily wear in both eyes prior to Visit 1:

* All Bausch \& Lomb PureVision lens types
* All Alcon Air Optix lens types
* All CooperVision Biofinity lens types
* All Vistakon Acuvue Oasys lens types
* Any conventional hydrogel Group IV lens
4. Vision correctable through spherocylindrical refraction to 32 letters (0.3 logMAR) or better (distance, high contrast) in each eye.
5. Clear central corneas and free of any anterior segment disorders
6. Habitual use of a Multi-Purpose Solution for cleaning, disinfecting, and storage of lenses.
7. Lens correction in both eyes is required and the same brand of lens is worn in each eye.
8. Agree to wear study lenses in both eyes on a daily wear basis, with lenses removed every night (not slept in) throughout the study period and no lens or pair of lenses worn for longer than 2 weeks.
9. Able and willing to comply with all care regimen and follow-up study procedures.

Exclusion Criteria

1. Females of childbearing potential (not surgically sterilized or postmenopausal) if any one of the following conditions are met:

* currently pregnant,
* plan to become pregnant during the study,
* are breast-feeding.
2. Wear of gas permeable contact lenses within the last 30 days.
3. Wear of polymethylmethacrylate lenses within the last 3 months.
4. No topical ocular prescription medications may be administered during the study period. Ongoing use of non-preserved artificial tears up to 4 times daily (with no changes in frequency or brand) is allowed. Ongoing use of the rewetting drop the subject customarily uses (with no switch in brand or type) is also permitted during the study period.
5. Current systemic disease affecting ocular health or use of topical or systemic medications that, in the Investigator's opinion, could affect ocular physiology or lens performance.
6. Ocular astigmatism of 2.00 D or greater in either eye based on the contact lens prescription.
7. Grade 2 or greater finding on any slit-lamp scale and/or corneal infiltrates of any grade during slit-lamp examination at Screening.
8. Any finding during slit-lamp examination that, in the Investigator's opinion, interferes with contact lens wear.
9. Scar or neovascularization within the central 4 millimeters (mm) of the cornea. Minor peripheral corneal scarring (that does not extend into the central zone) is permitted, if in the Investigator's judgment, it does not interfere with contact lens wear.
10. Aphakia.
11. Amblyopia.
12. History of any corneal surgery.
13. Allergy to any component of the study solutions.
14. Participation in any clinical study within the 2 weeks prior to entry into this study.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No